About Sydnexis
Sydnexis is a private company based in Del Mar, California. It has reported $72,267,322 raised in four offerings on Form D since October 2017. Its chief executive is Perry Sternberg.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 3, 2025 | Apr 15, 2025 | $20,000,000fully sold | 23 | $869K | Options, Securities on exercise, Convertible promissory notes convertible into equity securities of the Issuer.Rule 506(b) | Form D ↗ |
| Apr 24, 2024 | May 6, 2024 | $999,807of $8.4M target | 30 | $33,327 | Equity, OptionsRule 506(b) | Form D ↗ |
| Aug 6, 2021 | Aug 18, 2021 | $45,767,548fully sold | 26 | $1.7M | Equity, OptionsRule 506(b) | Form D ↗ |
| Oct 6, 2017 | Oct 20, 2017 | $5,499,967of $34.9M target | 6 | $916K | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $72,267,322 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Sydnexis's Form D filed Apr 15, 2025.
MJ
Mary Johnson
Executive officer
ZS
PJ
Patrick Johnson
Executive officer and promoter
PS
Perry Sternberg
CEO and director
JW
TS
Juliet Bakker
Director
Also a co-founder and managing director at Endogenex and a director at Nalu Medical.
RL
Richard Lindstrom
Director
Earlier filings also listed Zachary Scheiner (director, last listed Aug 2021), Kenneth Widder (ceo and director, last listed Aug 2021), Greg Grunberg (director, last listed Aug 2021), Kevin Johnson (director, last listed Oct 2017) and Greg Ostrow (executive officer and director, last listed Oct 2017).